Teladoc, Inc. (NYSE: TDOC) (“Teladoc”) today announced a
proposed offering of shares of its common stock, which includes
5,400,000 shares offered by Teladoc and 1,850,000 shares offered by
certain stockholders of Teladoc named in the preliminary prospectus
supplement (the “selling stockholders”). The underwriters have a
30-day option to purchase up to an additional 1,087,500 shares of
common stock from Teladoc.
The proceeds of the primary portion of the offering will be used
by Teladoc for working capital and general corporate purposes,
including to expand its current business through acquisitions of,
or investments in, other businesses, products or technologies.
Teladoc will not receive any proceeds from shares of common stock
to be sold by the selling stockholders.
J.P. Morgan and Piper Jaffray & Co. are acting as joint
book-running managers for the offering and as representatives of
the underwriters. Wells Fargo Securities and William Blair are also
acting as joint book-running managers for the offering. SunTrust
Robinson Humphrey and Oppenheimer & Co. are acting as
co-managers for the offering.
A copy of the preliminary prospectus supplement and the
accompanying prospectus related to the offering may be obtained
from J.P. Morgan, Attention: Broadridge Financial Solutions, 1155
Long Island Avenue, Edgewood, New York, 11717, or by telephone:
(866) 803-9204; or from Piper Jaffray & Co., Attention:
Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN
55402, or by email at prospectus@pjc.com, or by phone at (800)
747-3924.
A registration statement (including a prospectus) relating to
these securities has been filed with the U.S. Securities and
Exchange Commission (the “SEC”) and has become effective. This
offering may be made only by means of a prospectus supplement and
accompanying prospectus. Before you invest, you should read the
prospectus supplement and the accompanying prospectus in that
registration statement and other documents filed with the SEC for
more information about Teladoc and this offering. You may obtain
these documents free of charge by visiting the SEC’s website at
www.sec.gov.
This press release shall not constitute an offer to sell or a
solicitation of an offer to buy these securities, nor shall there
be any sale of these securities in any state or jurisdiction in
which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state or jurisdiction.
About Teladoc
Teladoc, Inc. (NYSE:TDOC) is the nation’s leading provider of
telehealth services and a pioneering force in bringing the virtual
care visit into the mainstream of today’s health care ecosystem.
Serving over 7,500 clients — including health plans, health
systems, employers and other organizations — more than 17 million
members can use phone, mobile devices and secure online video to
connect within minutes to Teladoc’s network of more than 3,000
board-certified, state-licensed physicians and behavioral health
specialists, 24/7. With national coverage, a robust, scalable
platform and a Lewisville, Texas-based member services center
staffed by 400 employees, Teladoc offers the industry’s most
comprehensive and complete telehealth solution, including primary
care, behavioral health care, dermatology, tobacco cessation and
more.
Cautionary Note Regarding
Forward-Looking Statements
This press release contains “forward-looking statements” within
the meaning of the safe harbor provisions of the U.S. Private
Securities Litigation Reform Act of 1995. Forward-looking
statements can be identified by words such as: “anticipate,”
“intend,” “plan,” “believe,” “project,” “estimate,” “expect,”
“may,” “should,” “will” and similar references to future periods.
Examples of forward-looking statements include, among others,
statements we make regarding our financing plans (including
statements related to the offering of common stock by us and the
selling stockholders and the intended use of net proceeds of the
offering), future revenues, future earnings, future numbers of
members or clients, litigation outcomes, regulatory developments,
market developments, new products and growth strategies, and the
effects of any of the foregoing on our future results of operations
or financial conditions.
Forward-looking statements are neither historical facts nor
assurances of future performance. Instead, they are based only on
our current beliefs, expectations and assumptions regarding the
future of our business, future plans and strategies, projections,
anticipated events and trends, the economy and other future
conditions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties, risks and
changes in circumstances that are difficult to predict and many of
which are outside of our control. Our actual results and financial
condition may differ materially from those indicated in the
forward-looking statements. Therefore, you should not rely on any
of these forward-looking statements. Important factors that could
cause our actual results and financial condition to differ
materially from those indicated in the forward-looking statements
include, among others, the following: (i) changes in laws and
regulations applicable to our business model; (ii) changes in
market conditions and receptivity to our services and offerings;
(iii) results of litigation; (iv) the loss of one or more
key clients; and (v) changes to our abilities to recruit and
retain qualified providers into our network. Additional relevant
risks that may affect our results are described in certain of our
filings with the SEC.
Any forward-looking statement made by us in this press release
is based only on information currently available to us and speaks
only as of the date on which it is made. We undertake no obligation
to publicly update any forward-looking statement, whether written
or oral, that may be made from time to time, whether as a result of
new information, future developments or otherwise.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170117006470/en/
For Teladoc, Inc.Investors:Jisoo Suh,
914-265-6706jsuh@teladoc.comorBob East,
443-213-0500teladoc@westwicke.comorMedia:Courtney McLeod,
203-253-3257cmcleod@teladoc.com
Teladoc Health (NYSE:TDOC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teladoc Health (NYSE:TDOC)
Historical Stock Chart
From Apr 2023 to Apr 2024